Difference between revisions of "Part:BBa K4291008"
Line 14: | Line 14: | ||
== Construct design == | == Construct design == | ||
Because the T7 promoter and T7 RNA polymerase have strong ability in translation and usually be used as protein expression, we chose pET28a-vector and E. coli BL21(DE3), with T7 promoter and T7 RNA polymerase respectively, to express our target protein inak-gldh. To achieve this, we optimized the DNA sequences of inak-gldh and inserted them into the HindIII and NcoI sites of the pET28a vector (Figure 1.), and transformed the recombinant plasmid into E. coli BL21(DE3) for protein expression. | Because the T7 promoter and T7 RNA polymerase have strong ability in translation and usually be used as protein expression, we chose pET28a-vector and E. coli BL21(DE3), with T7 promoter and T7 RNA polymerase respectively, to express our target protein inak-gldh. To achieve this, we optimized the DNA sequences of inak-gldh and inserted them into the HindIII and NcoI sites of the pET28a vector (Figure 1.), and transformed the recombinant plasmid into E. coli BL21(DE3) for protein expression. | ||
− | [[ | + | [[File:T--Canton HS--BBa K4291008-figure 11.png|500px|thumb|center|Figure 1. Map of pET28a- inak-gldh plasmid]] |
=== BBa_K4291006 === | === BBa_K4291006 === | ||
Line 33: | Line 33: | ||
1.1 Verification by double-enzyme digestion | 1.1 Verification by double-enzyme digestion | ||
To build the plasmid, we let the synthetic company synthesize the DNA fragment of optimized inak-gldh and inserted it into the HindIII and NcoI sites of the pET28a vector (Figure 2A). Then, we send it to the company for Sanger sequencing. The returned sequencing comparison results showed that there were no mutations in the gene region (Figure 2B), and the plasmid pET28a- inak-gldh was successfully constructed. And the next step was extracting the recombinant plasmid and transforming it into E. coli BL21(DE3) competent cells. meanwhile, the plasmid was extracted and performed double-enzyme digestion to conform if the bacteria contain the plasmid. After that, the bacteria was used to express the inak-gldh proteins. | To build the plasmid, we let the synthetic company synthesize the DNA fragment of optimized inak-gldh and inserted it into the HindIII and NcoI sites of the pET28a vector (Figure 2A). Then, we send it to the company for Sanger sequencing. The returned sequencing comparison results showed that there were no mutations in the gene region (Figure 2B), and the plasmid pET28a- inak-gldh was successfully constructed. And the next step was extracting the recombinant plasmid and transforming it into E. coli BL21(DE3) competent cells. meanwhile, the plasmid was extracted and performed double-enzyme digestion to conform if the bacteria contain the plasmid. After that, the bacteria was used to express the inak-gldh proteins. | ||
− | [[ | + | [[File:T--Canton HS--BBa K4291008-figure 2.jpg|500px|thumb|center|Figure 2. double-enzyme digestion result ]] |
1.2 Sanger sequencing of recombinant plasmid | 1.2 Sanger sequencing of recombinant plasmid |
Revision as of 09:44, 26 September 2022
T7 pro- His tag-Lac operate-T7 tag-inaK-gldh-T7 ter
T7 pro- His tag-Lac operate-T7 tag-inaK-gldh-T7 ter
Characterization by Canton_HS
BBa_K4291008
Name: T7 pro- His tag-Lac operate-T7 tag-inaK-gldh-T7 ter Base Pairs: 1485 bp Origin: Pseudomonas syringae and E.coli Properties: a tool to display the glutamate dehydrogenase on the surface of bacteria
Usage and biology
Glutamate dehydrogenase (gldh) is a mitochondrial enzyme that is involved in the metabolism of glutamate to 2-oxoglutarate, and reversibly converts glutamate to α-ketoglutarate as part of the urea cycle. The gldh enzyme is found primarily in the liver, kidney, and cardiac muscle, while the liver has the highest concentration of gldh activity and lower levels in the brain, skeletal muscle, and leukocytes. GLDH has a housekeeping role in cell metabolism. In addition, the bacteria such E.coli also use the NADP+-specific GLDH to disposal of inorganic nitrogen.
Construct design
Because the T7 promoter and T7 RNA polymerase have strong ability in translation and usually be used as protein expression, we chose pET28a-vector and E. coli BL21(DE3), with T7 promoter and T7 RNA polymerase respectively, to express our target protein inak-gldh. To achieve this, we optimized the DNA sequences of inak-gldh and inserted them into the HindIII and NcoI sites of the pET28a vector (Figure 1.), and transformed the recombinant plasmid into E. coli BL21(DE3) for protein expression.
BBa_K4291006
Name: inak Base Pairs: 537 bp Origin: Pseudomonas syringae Properties: carrier protein in bacterial surface display system
Usage and biology
BBa_K4291006 is an encoding sequence of ice nucleation protein (inaK), which anchors in extracellular membrane using N-terminal domain. The C-terminal is used to fused target protein such as vaccines, enzymes and viral protein which displayed on the surface of bacteria.
K4291007
Name: gldh Base Pairs: 1260 bp Origin: E.coli Properties: NADP-dependent glutamate dehydrogenase
Usage and biology
BBa_K4291006 is an encoding sequence of glutamate dehydrogenase (gldh). The NADP-dependent glutamate dehydrogenase has capacity of conversion the glutamate to α-ketoglutarate and ammonia.
Experimental approach
1.1 Verification by double-enzyme digestion To build the plasmid, we let the synthetic company synthesize the DNA fragment of optimized inak-gldh and inserted it into the HindIII and NcoI sites of the pET28a vector (Figure 2A). Then, we send it to the company for Sanger sequencing. The returned sequencing comparison results showed that there were no mutations in the gene region (Figure 2B), and the plasmid pET28a- inak-gldh was successfully constructed. And the next step was extracting the recombinant plasmid and transforming it into E. coli BL21(DE3) competent cells. meanwhile, the plasmid was extracted and performed double-enzyme digestion to conform if the bacteria contain the plasmid. After that, the bacteria was used to express the inak-gldh proteins.
1.2 Sanger sequencing of recombinant plasmid In addition, we sent the plasmid to the company for Sanger sequencing. The certificate of recombinant plasmid sequencing results is as Figure3.
Proof of function
2.1 protein purification In order to verify the inak-gldh protein expression level, we cultured pET28a- inak-gldh containing BL21(DE3) strain in the LB medium and added IPTG to induce protein expression when the OD600 reached 0.6. After overnight induction and culture, we collected the cells and ultrasonic fragmentation of cells to release the intracellular proteins. Next, we used the SDS-PAGE method to verify the expression level of the target protein (Figure 3). As a result, we could significantly find the band at the correct size.
Sequence and Features
- 10COMPATIBLE WITH RFC[10]
- 12INCOMPATIBLE WITH RFC[12]Illegal NheI site found at 161
- 21INCOMPATIBLE WITH RFC[21]Illegal XhoI site found at 573
Illegal XhoI site found at 1344
Illegal XhoI site found at 1386 - 23COMPATIBLE WITH RFC[23]
- 25INCOMPATIBLE WITH RFC[25]Illegal NgoMIV site found at 759
Illegal AgeI site found at 1263 - 1000INCOMPATIBLE WITH RFC[1000]Illegal BsaI site found at 945
Illegal BsaI site found at 1194